Cancer BiologybioRxiv
Arginase 1 is a key driver of immune suppression in pancreatic cancer
R. E. Menjivar, Z. C. Nwosu, W. Du…·M. di Magliano
This study shows that Arginase 1 suppresses immune responses in pancreatic cancer by inhibiting T cell activation, and targeting it enhances immunotherapy effectiveness.